189 related articles for article (PubMed ID: 38539199)
1. Insight into antioxidant-like activity and computational exploration of identified bioactive compounds in Talinum triangulare (Jacq.) aqueous extract as potential cholinesterase inhibitors.
Afolabi OB; Olasehinde OR; Owolabi OV; Jaiyesimi KF; Adewumi FD; Idowu OT; Mabayoje SO; Obajuluwa AO; Akpor OB
BMC Complement Med Ther; 2024 Mar; 24(1):134. PubMed ID: 38539199
[TBL] [Abstract][Full Text] [Related]
2. HPLC-DAD finger printing, antioxidant, cholinesterase, and α-glucosidase inhibitory potentials of a novel plant Olax nana.
Ovais M; Ayaz M; Khalil AT; Shah SA; Jan MS; Raza A; Shahid M; Shinwari ZK
BMC Complement Altern Med; 2018 Jan; 18(1):1. PubMed ID: 29295712
[TBL] [Abstract][Full Text] [Related]
3. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
Saliu JA; Olabiyi AA
Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
[TBL] [Abstract][Full Text] [Related]
4. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.
Ayaz M; Junaid M; Ullah F; Sadiq A; Khan MA; Ahmad W; Shah MR; Imran M; Ahmad S
Lipids Health Dis; 2015 Nov; 14():141. PubMed ID: 26530857
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies.
Afolabi OB; Olasehinde OR; Olanipon DG; Mabayoje SO; Familua OM; Jaiyesimi KF; Agboola EK; Idowu TO; Obafemi OT; Olaoye OA; Oloyede OI
BMC Complement Med Ther; 2023 Jun; 23(1):203. PubMed ID: 37337198
[TBL] [Abstract][Full Text] [Related]
6. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
7. Anticholinesterase and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer's and other neurological disorders.
Kamal Z; Ullah F; Ayaz M; Sadiq A; Ahmad S; Zeb A; Hussain A; Imran M
Biol Res; 2015 Apr; 48(1):21. PubMed ID: 25889712
[TBL] [Abstract][Full Text] [Related]
8. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
9. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
[TBL] [Abstract][Full Text] [Related]
10. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease.
Dash UC; Kanhar S; Dixit A; Dandapat J; Sahoo AK
Bioorg Chem; 2019 Jul; 88():102947. PubMed ID: 31028989
[TBL] [Abstract][Full Text] [Related]
11. Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus.
Zeb A; Sadiq A; Ullah F; Ahmad S; Ayaz M
Biol Res; 2014 Dec; 47(1):76. PubMed ID: 25723481
[TBL] [Abstract][Full Text] [Related]
12. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
15. Chromatographic fingerprint analysis, antioxidant properties, and inhibition of cholinergic enzymes (acetylcholinesterase and butyrylcholinesterase) of phenolic extracts from Irvingia gabonensis (Aubry-Lecomte ex O'Rorke) Baill bark.
Ojo OA; Ojo AB; Ajiboye BO; Oyinloye BE; Akinyemi AJ; Okesola MA; Boligon AA; de Campos MMA
J Basic Clin Physiol Pharmacol; 2018 Mar; 29(2):217-224. PubMed ID: 29381472
[TBL] [Abstract][Full Text] [Related]
16. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant, Antidiabetic, Anticholinergic, and Antiglaucoma Effects of Magnofluorine.
Durmaz L; Kiziltas H; Guven L; Karagecili H; Alwasel S; Gulcin İ
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144638
[TBL] [Abstract][Full Text] [Related]
19. Phytochemical contents, antioxidant effects, and inhibitory activities of key enzymes associated with Alzheimer's disease, ulcer, and skin disorders of Sideritis albiflora and Sideritis leptoclada.
Deveci E; Tel-Çayan G; Duru ME; Öztürk M
J Food Biochem; 2019 Dec; 43(12):e13078. PubMed ID: 31609004
[TBL] [Abstract][Full Text] [Related]
20. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
